- Advancing Gastroenterology and Hepatology through Creative Integration
- Abstract Submission and Registration are available via APDW 2018 website (www.apdw2018.org)
SIDDS 1 | ||
Nov. 16 (Fri) 08:30-10:00 |
Understanding of molecular alteration: the cornerstone for treatment of GI cancer | 202 (2F) |
Chairperson(s) | James R. Goldenring (Nashville), Seung Woo Park (Seoul) | |
08:30-08:55 | The mechanisms responsible for the development of pre-neoplastic lineages from metaplasias in the stomach and their roles in gastric carcinogenesis | James R. Goldenring (Nashville) |
08:55-09:20 | Proteomic Multi-Marker Panel for Early Detection of GI cancers Using Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS) | Youngsoo Kim (Seoul) |
09:20-09:45 | Control of GI cancer using CRIPR-Cas9 | Hyongbum Kim (Seoul) |
09:40-10:00 | Q&As |
E-poster Presentation-01 (UG, Motility) | ||
Nov. 16 (Fri) 08:30-10:00 |
Esophagus | R1A (3F) |
Chairperson(s) | Jung-Ho Park (Seoul), William Tam (Adelaide) | |
08:30-08:36 | Utility of adjunctive rapid drink test (RDT) during high resolution esophageal manometry (HREM) in sitting position for evaluating functional esophagogastric junction outflow obstruction (EGJOO) | Tanisa Patcharatrakul (Bangkok) |
08:36-08:42 | Reduction of proton pump inhibitor (PPI) usage in patients with gastroesophageal reflux disease (GERD) after undergoing stretta procedure, an east malaysia perspective. | Phei Oon Tan (Kota Kinabalu) |
08:42-08:48 | The relationship between hypomotility disorders, hypotensive lower esophageal sphincter and gastroesophageal reflux diseases symptoms. | Hang Dao (Hanoi) |
08:48-08:54 | Taking the next steps in endoscopic visual assessment of barretts esophagus | Roxana Chis (Kingston) |
08:54-09:00 | Do we need to exclude epigastric symptoms for GERD diagnosis? | Mengyu Zhang (Guangzhou) |
09:00-09:06 | Effect of anti-reflux mucosectomy (ARMS) for refractory GERD underwent 24-hour pH-impedance (MII-pH) off PPI before and after ARMS | Kazuya Sumi (Tokyo) |
09:06-09:12 | Immunohistochemical expression of transient receptor vanilloid 4 (TRPV4), a marker of visceral hypersensitivity in NERD and controls | Mung Seong Wong (Kota Bharu) |
09:12-09:18 | Normative values for 24-hours ambulatory multichannel intraluminal impedance and pH monitoring (sandhill and MMS systems) in the malay population | Su Fui Thung (Kota Bharu) |
09:18-09:24 | Normative Chicago 3.0 metrics for high-resolution esophageal manometry (sandhill and MMS systems) in the malay population and the effects of boluses types and postures on normative Metrics | Su Fui Thung (Kota Bharu) |
09:24-09:30 | Effects of provocative bolus and positions on chicago 3.0 metrics in normal malay population. | Su Fui Thung (Kota Bharu) |
09:30-09:36 | Clinical characteristics of untreated achalasia patients in Taiwan: a prospective study based on high-resolution impedance manometry | Ping-Huei Tseng (Taipei) |
09:36-09:42 | Prevalence and risk factors of Barrett's esophagus in Vietnamese patients with upper gastrointestinal symptoms | Quyen Thi Trieu Pham (Ho Chi Minh) |
09:42-09:48 | The endoscopic and clinicopathological characteristics of Barrett's esophagus in Vietnamese patients | Truc Le Thanh Tran (Ho Chi Minh) |
09:48-09:54 | Pneumatic dilation, more than a treatment of achalasia - evaluation of compliance of esophagogastric junction by pneumatic dilation balloon before POEM | Hailong Cao (Tianjin) |
E-poster Presentations-02 (LG) | ||
Nov. 16 (Fri) 08:30-10:00 |
Inflammatory bowel disease (1) | R1C (3F) |
Chairperson(s) | Tae Oh Kim (Busan), Chang Hwan Choi (Seoul) | |
08:30-08:36 | Do patients, their families, and doctors really think the same? A population-based, multi-centered cohort study using the inflammatory bowel disease disability index | Jun Shen (Shanghai) |
08:36-08:42 | Using magnetic resonance imaging to evaluate the effectiveness in perianal fistulising Crohns disease | Jun Shen (Shanghai) |
08:42-08:48 | Distinct cutoff values of adalimumab trough levels are associated with different therapeutic outcomes in patients with inflammatory bowel disease | Sang Hyoung Park (Seoul) |
08:48-08:54 | Endoscopic diagnosis of non-pedunculated dysplasia during surveillance in the ulcerative colitis: a survey-based, multinational studies | Dong-Hoon Yang (Seoul) |
08:54-09:00 | Infliximab trough levels are associated with transmural healing during maintenance treatment in pediatric Crohn's disease patients | Ben Kang (Daegu) |
09:00-09:06 | Impact of superimposed cytomegalovirus infection on the outcomes of ulcerative colitis flare-up | Shin Ju Oh (Seoul) |
09:06-09:12 | Histone H3 acetylation protects ulcerative colitis by inhibiting NF-B/p65 and enhancing intestinal epithelial barrier function | Chunxiao Li (Hangzhou) |
09:12-09:18 | Helicobacter pylori infection in inflammatory bowel disease: protective or harmful? | Yang Yu (Beijing) |
09:18-09:24 | The Efficacy and safety of adalimumab for the patients with moderate to severely active ulcerative colitis and predictors of response in Korea (EUREKA): preliminary results | Chang Hwan Choi (Seoul) |
09:24-09:30 | Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring | Sung-Shuo Kao (Kaohsiung) |
09:30-09:36 | Doctors perspectives on the use of traditional, complementary and alternative medicine in inflammatory bowel disease: the first doctors report in Asia | Jessica Y L Ching (Hong Kong) |
E-poster Presentations-03 (LV) | ||
Nov. 16 (Fri) 08:30-10:00 |
Acute hepatitis, viral hepatitis, liver failure, HCC | R2A (3F) |
Chairperson(s) | Jong Young Choi (Seoul), Young Oh Kwon (Daegu) | |
08:30-08:36 | Hormonal component of the pathogenesis of chronic liver disease | Saidrakhim Nodirovich Lukmonov (Tashkent) |
08:36-08:42 | Inflammatory cytokines and the change of Th1/Th2 balance as prognostic indicators for HCC in patients treated with transarterial chemoembolization | Hae Lim Lee (Bucheon) |
08:42-08:48 | Clinical characteristics of long term survivors following sorafenib treatment for unresectable hepatocellular carcinoma: Korean national multi-center retrospective cohort study | Young Youn Cho (Seoul) |
08:48-08:54 | Assessing HCV distribution among hard to reach populations in London using whole genome sequencing: report from the TB reach study | Dewi Nur Aisyah (Depok) |
08:54-09:00 | Modelling hepatitis C direct acting antiviral (DAA) treatment scale up among people who inject drugs in London: working towards WHO incidence elimination target by 2030 | Dewi Nur Aisyah (Depok) |
09:00-09:06 | Evaluation of utility of predictive models for acute-on-chronic liver failure | Li Peng Margaret Teng (Singapore) |
09:06-09:12 | Early hepatitis is the strongest risk factor for the development of severe dengue infection: a points-based risk-score to predict critical disease in dengue fever | Madunil Anuk Niriella (Ragama) |
09:12-09:18 | Barriers to hepatocellular carcinoma (HCC) surveillance in at-risk individuals in Thailand | Palada Pitakkitnukun (Bangkok) |
09:18-09:24 | Temporal profile of HEV RNA concentration in blood and stool in patients with acute hepatitis E | Vijay Kumar Halkurike Jayadevappa (Lucknow) |
09:24-09:30 | miRNA-221-5p promotes epithelial-mesenchymal transition in hepatocellular carcinoma through regulation of CD44/TGF-beta1 | Na Ri Park (Seoul) |
09:30-09:36 | Understanding recurrence related oncogenic kinases and metabolites in liver cancer | Hongping Xia (Singapore) |
E-poster Presentations-04 (LG) | ||
Nov. 16 (Fri) 08:30-10:00 |
Irritable bowel disease (IBS), microbiology | R2C (3F) |
Chairperson(s) | Byung Ik Jang (Daegu), Shengtao Zhu (Beijing) | |
08:30-08:36 | Maternal western-style diet alters gut microbiota of offspring and exacerbates intestinal inflammation in adulthood | Hailong Cao (Tianjin) |
08:36-08:42 | Profiles of bacteria-derived extracellular vesicles in stool, serum and urine in patients with colorectal cancer: a preliminary study | Jae Ho Cho (Seongnam) |
08:42-08:48 | Characteristics of mucosa-associated fungal microbiota during treatment in Crohn's disease | Cong He (Nanchang) |
08:48-08:54 | The impact of helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: an open-label, prospective clinical trial | Luyi Chen (Hangzhou) |
08:54-09:00 | Bloating and its association with functional gastrointestinal disorders according to ROME III diagnostic criteria | Kewin Tien Ho Siah (Singapore) |
09:00-09:06 | Transcriptome and methylome profiling in a rat model of irritable bowel syndrome induced by stress | Shengtao Zhu (Beijing) |
09:06-09:12 | Investigating the functional role of clostridium hathewayi in colorectal carcinogenesis | Thomas Kwong (Hong Kong) |
09:12-09:18 | The impact of veterinary antibiotic residue in foods on obesity and antibiotic resistance through modulation of gut microbiota | Wei-Kai Wu (Taipei) |
09:18-09:24 | Overlapping functional GI disorders (FGID) and new-onset constipation associated with more GI symptom severity in FGID patients during hospitalization | Tanisa Patcharatrakul (Bangkok) |
Mastering NBI | ||
Nov. 16 (Fri) 08:50-11:40 |
Mastering NBI - Collaboration with ANBIIG | 205 (2F) |
Chairperson(s) | Rajvinder Singh (Adelaide), Bo-In Lee (Seoul) | |
08:50 - 09:10 | NBI in the Oesophagus: Current and best practice, 2018 | Rajvinder Singh (Adelaide) |
09:10 - 09:25 | Case discussion: esophagus | Jung-Wook Kim (Seoul) |
09:25 - 09:45 | NBI detection and characterization of stomach cancers | Mitsuhiro Fujishiro (Tokyo) |
09:45 - 10:00 | Case discussion: stomach | Jun-Hyung Cho (Seoul) |
10:30 - 10:50 | NBI detection and characterization of colorectal polyps | Nozomu Kobayashi (Tochigi) |
10:50 - 11:05 | Case discussion: colon, histologic prediction | Han Hee Lee (Seoul) |
11:05 - 11:25 | Estimation of invasion depth in colorectal lesions | David Hewett (Brisbane) |
11:25 - 11:40 | Case discussion: estimation of invasion depth | Yunho Jung (Cheonan) |
SIDDS 2 | ||
Nov. 16 (Fri) 10:30-12:00 |
Host-microbiome interactions in Gut and Liver disease | 202 (2F) |
Chairperson(s) | Takanori Kanai (Tokyo), Jin-Wook Kim (Seongnam) | |
10:30-10:50 | Understanding human gut microbiome and diseases | Jongsik Chun (Seoul) |
10:50-11:10 | The innate immune capacity of macrophages in regulation of intestinal barrier function and inflammation | Eunok Im (Busan) |
11:10-11:30 | T cells and immunoregulatory cytokines in intestinal inflammation: implication on IBD treatment | Takanori Kanai (Tokyo) |
11:30-11:50 | Gut-liver axis in Liver diseases | Ki Tae Suk (Chuncheon) |
11:50-12:00 | Q&As |
Plenary 2 (UG, LG, Motility) | ||
Nov. 16 (Fri) 10:30-12:00 |
KDDW Plenary 2 (UG, LG, Motility) | 203 (2F) |
Chairperson(s) | Yong Chan Lee (Seoul), Tae Il Kim (Seoul), In Kyung Sung (Seoul) | |
10:30-10:45 | Trough levels of infliximab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn's disease on infliximab maintenance therapy | Eun Hye Oh (Seoul) |
10:45-11:00 | Link between symptom severity, gender and self-reported psychiatric disorders in patients with organic and functional gastrointestinal disorders: A prospective cohort study in 12,806 consecutive patients referred for specialist treatment at a tertiary cen | Ayesha Shah (Brisbane) |
11:00-11:15 | utility of measurement EGJ distensibility in patients with achalasia | Junsu Chang (Sungnam) |
11:15-11:30 | Transient Receptor Vanilloid 4 (TRPV4), a Marker of Visceral Hypersensitivity is present in NERD and Controls | Nazihah Azis (Kota Bharu) |
11:30-11:45 | Metachronous recurrence of gastric epithelial neoplasia according to Helicobacter pylori infection and microsatellite state : Long term follow-up results and clinical outcome | Jaeyoung Kim (Suwon) |
11:45-12:00 | Association between family history of colorectal cancer and the risk of metachronous colorectal neoplasia following polypectomy in patients aged <50 years | Hyun Beom Chae (Seoul) |
Okuda Lectureship | ||
Nov. 16 (Fri) 11:00-11:30 |
Okuda Lectureship | Auditorium (3F) |
Chairperson(s) | Rakesh Aggarwal (Lucknow), Yungsang Lee (Seoul) | |
11:00-11:30 | Challenges of hepatitis B in the era of antiviral therapy | Henry LY Chan (Hong Kong) |
Marshall & Warren Lectureship | ||
Nov. 16 (Fri) 11:30-12:00 |
Marshall & Warren Lectureship | Auditorium (3F) |
Chairperson(s) | Ian Roberts-Thomson (Hawthorn), Hyun Chae Jung (Seoul) | |
11:30-12:00 | Chemoprevention of gastric cancer by H. pylori eradication and its underlying mechanism | Nayoung Kim (Seongnam) |
Combined-01 (Liver, PB) | ||
Nov. 16 (Fri) 14:00-15:30 |
Autoimmune diseases of the liver and biliary system: the essentials | 105 (1F) |
Chairperson(s) | Myung-Hwan Kim (Seoul), Sook-Hyang Jeong (Seongnam) | |
14:00-14:20 | Autoimmune hepatitis - 2018 Update | Atsushi Tanaka (Tokyo) |
14:20-14:40 | Primary biliary cholangitis: from diagnosis to treatment | Kyung-Ah Kim (Goyang) |
14:40-15:00 | Primary sclerosing cholangitis: what is the best management in the 21stcentury? | Hiroyuki Isayama (Tokyo) |
15:00-15:20 | IgG4-related sclerosing cholangitis: when to suspect, how to diagnose, and how to treat | Taejun Song (Seoul) |
15:20-15:30 | Q&As |
APDW 2018 Plenary Oral 1 | ||
Nov. 16 (Fri) 14:00-15:30 |
Plenary Oral 1 | 205A (2F) |
Chairperson(s) | Jidong Jia (Beijing), Dong Ki Lee (Seoul) | |
14:00-14:10 | EUS-guided gastrojejunostomy using a lumen apposing metal stent in patients with symptomatic gastric outlet obstruction | Adeel Urrehman (Karachi) |
14:10-14:20 | Higher peak dose rather than prolonged duration of corticosteroid increases the risk of hepatitis flare in patients with chronic hepatitis B | Becky Wing-Yan Yuen (Shatin) |
14:20-14:30 | Roux en Y gastric bypass is associated with better short term cardiovascular risk reduction than sleeve gastrectomy in a multi-ethnic cohort | Baldwin Po Man Yeung (Singapore) |
14:30-14:40 | Incidence and risk factors for alcohol relapse after liver transplantation for alcoholic liver disease. | Dong Hyun Sinn (Seoul) |
14:40-14:50 | New staining method using antibody of methionyl-tRNA synthetase for brushing cytology can differentiate indeterminate bile duct strictures. | Sung Ill Jang (Seoul) |
14:50-15:00 | Is the new T1 category defined by the 8th edition AJCC pancreatic cancer staging system an improvement? An evaluation by multinational data | Wooil Kwon (Seoul) |
15:10-15:20 | PCSK9 inhibits HCC cell malignant biological behavior via binding to GSTP1 | Mingyan He (Nanchang) |
E-poster Presentations-05 (UG) | ||
Nov. 16 (Fri) 14:00-15:30 |
H. pylori | R1A (3F) |
Chairperson(s) | Jung Mogg Kim (Seoul), Khien Van Vu (Hanoi) | |
14:00-14:06 | Prevalence of helicobacter pylori in eastern province Mongolia | Munkhtur Dandar (Choibalsan) |
14:06-14:12 | The role of migration inhibitory factor (MIF) in H. pylori infection and gastric cancer development | Chun-Sheng Shen (Kaohsiung) |
14:12-14:18 | Management of antibiotics-resistant helicobacter pylori infection -Perspectives from Vietnam | Khien Van Vu (Hanoi City) |
14:18-14:24 | Risk of overall mortality after helicobacter pylori treatment in patients with hypertension | Young-Il Kim (Goyang) |
14:24-14:30 | Efficacies of genotypic resistance-guided vs empirical therapy for refractory helicobacter pylori infection- A randomized controlled trial | Jyh-Ming Liou (Taipei) |
14:30-14:36 | Discriminating subjects with past helicobacter pylori infection among seronegative and unimpaired gastric secretory ability. | Hyungyung Kwon (Seoul) |
14:36-14:42 | Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria | Ping-I Hsu (Kaohsiung) |
14:42-14:48 | Modified amoxicillin triple therapy vs standard triple therapy for eradication of helicobacter pylori infection: A randomized control trial | Dennis Franco Fernandez (Manila) |
14:48-14:54 | The microbiota regulates bone marrow-derived mesenchymal stem cells in gastrointestinal cancer | Huiying Shi (Wuhan) |
14:54-15:00 | Association of helicobacter pylori infection with fatty liver infiltration in dyspeptic patients | Basit Siddiqui (Karachi) |
15:00-15:06 | Online registry for nationwide database of current trend of helicobacter pylori eradication in Korea: correlation of the density of antibiotics usage with eradication success | Beom Jin Kim (Seoul) |
15:06-15:12 | 14-day bismuth high dose dual therapy is a robust second-line rescue therapy of H.pylori infection | Alex Hwong-Ruey Leow (Kuala Lumpur) |
E-poster Presentations-06 (LG) | ||
Nov. 16 (Fri) 14:00-15:30 |
Inflammatory bowel disease (2) | R1C (3F) |
Chairperson(s) | Young Sook Park (Seoul), Zhihua Ran (Shanghai) | |
14:00-14:06 | Efficacy of cumulative corticosteroid dose before the treatment with biologics on the outcome of UC patients: A retrospective multicenter experience | Yoshitaka Ueno (Hirosima) |
14:06-14:12 | Clinical significance of granulomas in Crohn`s disease: A meta-analysis | Seung Wook Hong (Seongnam) |
14:12-14:18 | Dose medical acceleration improve outcomes in ulcerative colitis patients who are in clinical remission but have endoscopic inflammation? | Ji Young Chang (Seoul) |
14:18-14:24 | Increased risk of end-stage renal disease in metabolically healthy patients with Crohn's disease : A nationwide population-based study | Seona Park (Seoul) |
14:24-14:30 | Increased risk of parkinson's disease in young patients with Crohn's disease: a nationwide population-based study | Seona Park (Seoul) |
14:30-14:36 | Increased risk of diabetes in inflammatory bowel disease: A nationwide population-based study in Korea | Eun Ae Kang (Seoul) |
14:36-14:42 | Increased risk of anxiety and depressive disorders associated with inflammatory bowel disease: a nationwide population-based study | Jaeyoung Chun (Seoul) |
14:42-14:48 | High-sensitivity C-reactive protein/albumin ratio are associated with disease activity of inflammatory bowel disease | Ailing Liu (Beijing) |
14:48-14:54 | Characteristics of extra-intestinal manifestations (EIM) in a local cohort of patients with inflammatory bowel disease (IBD) | Huiyu Lin (Singapore) |
14:54-15:00 | Microbial signature associated with prognosis of Crohns disease | Dong Il Park (Seoul) |
15:00-15:06 | A comparative study of infusion reactions associated with infliximab, vedolizumab and ustekinumab: Experience from a tertiary hospital in Singapore. | Andrew Xia Huang Tan (Singapore) |
15:06-15:12 | Low intestinal alkaline phosphatase ratio may predict clinical recurrence in patients with Crohn disease | Seon-Young Park (Gwangju) |
15:12-15:18 | Development of machine learning model to predict the prognosis in patients with inflammatory bowel disease (IBD) | Youni Choi (Inchoen) |
15:18-15:24 | Prevalence and associated factors of anemia in Taiwanese inflammatory bowel disease patients | Yew Loong Leong (Taipei) |
15:24-15:30 | Post-hoc analysis from the Phase 2 FITZROY study with the selective JAK1 inhibitor filgotinib: effect of disease duration and location on clinical remission in Crohns disease patients | Wai Keung Leung (Hong Kong) |
E-poster Presentations-07 (LV) | ||
Nov. 16 (Fri) 14:00-15:30 |
Alcoholic and nonalcoholic liver disease | R2A (3F) |
Chairperson(s) | Manoj Kumar Sharma (New Delhi), Sungjin Hong (Shanghai) | |
14:00-14:06 | Protocatechuic acid-mediated Sirtuin3 activation promotes fatty acid metabolism in non-alcoholic fatty liver disease | Jihong Yao (Dalian) |
14:06-14:12 | Effectiveness of probiotics in improving minimal hepatic encephalopathy in patients with compensated liver cirrhosis a meta-analysis | Higinio Mappala (Manila) |
14:12-14:18 | Antioxidants in patients with alcoholic liver disease | Le Thi Thu Hien (Thai Nguyen) |
14:18-14:24 | Relationship between cytokines and alcoholic liver disease | Le Thi Thu Hien (Thai Nguyen) |
14:24-14:30 | Severity of non-alcoholic fatty liver disease in Hong Kong and Australia | Nicole Phoebe Tanner (North Point) |
14:30-14:36 | Alcoholic fatty liver disease among unsafe drinkers: A prospective, community cohort, 7-year follow-up study | Madunil Anuk Niriella (Ragama) |
14:36-14:42 | Lifestyle Intervention enabled by mobile technologies leading to weight loss in patients with non-alcoholic fatty liver disease: a randomized controlled trial | Su Lin Lim (Singapore) |
14:42-14:48 | 5% weight loss induces NAFLD fibrosis as defined through interval elastography - Preliminary data from a single tertiary hospital in Singapore | Wei De Tee (Singapore) |
E-poster Presentations-08 (Surgery) | ||
Nov. 16 (Fri) 14:00-15:30 |
Surgery: Upper GI, lower GI, others | R2C (3F) |
Chairperson(s) | Kyo Young Song (Seoul), Kent-Man Chu (Hong Kong) | |
14:00-14:06 | Body mass index and mortality in patients with gastric cancer: A large cohort study | Jung Hwan Lee (Incheon) |
14:06-14:12 | Tranalation and valiadation of eortc qlq-cr29 quality of life questionnaire (sinhala version) | Dakshitha Wickramasinghe (Colombo) |
14:12-14:18 | Enhanced recovery after colorectal surgery (ERAS) protocol in Sri Lanka an assessment of current practice of colorectal surgery among general surgical units in a developing country in south Asia | Chamila Lakmal (Colombo) |
14:18-14:24 | Non-exposure simple suturing endoscopic full-thickness resection (NESS-EFTR) with sentinel basin dissection in patients with early gastric cancer | Bang Wool Eom (Goyang) |
14:24-14:30 | Survival outcomes of local excision versus radical resection for early colorectal cancer in young patients: A propensity matching study | Bin Cao (Beijing) |
14:30-14:36 | Treatment strategy of intraperitoneal and systemic chemotherapy combined with gastrectomy for gastric cancer with peritoneal metastasis | Daisuke Kobayashi (Nagoya) |
14:36-14:42 | A single institution experience of laparoscopic gastrectomy in advanced gastric cancer: analysis of postoperative morbidities and long-term oncologic outcomes | Sa-Hong Min (Seongnam) |
14:42-14:48 | Risk factor and treatments of chylothorax after esophageal cancer surgery | Moyuru Yamada (Toyonakacity) |
14:48-14:54 | A single center experience of 50 fundoplications in Hong Kong | Ho Kiu Grace Wong (Hong Kong) |
WEO Honorary Lecture | ||
Nov. 16 (Fri) 16:00-17:00 |
WEO Honorary Lectureship | 104 (1F) |
Chairperson(s) | Jean-Francois Rey (Saint Laurent Du Var) | |
16:00-16:50 | Paving the way to the globalization of advanced endoscopy | Hisao Tajiri (Tokyo) |
16:50-17:00 | Q&A |
Combined-02 (Endoscopy-Surgery) | ||
Nov. 16 (Fri) 16:00-17:30 |
Gastrointestinal diseases and treatments in obese patients (KSGE combined session) | 105 (1F) |
Chairperson(s) | Sung Kwan Shin (Seoul), Joo Ho Lee (Seoul) | |
16:00-16:20 | Functional gastrointestinal disorders in obese patients | Yong Sung Kim (Iksan) |
16:20-16:40 | Gastrointestinal tumors associated with obesity | Jin-Hyeok Hwang (Seongnam) |
16:40-17:00 | Endoscopic treatments for morbid obesity | Hyuk Soon Choi (Seoul) |
17:00-17:20 | Surgical treatments for morbid obesity | Takeshi Naitoh (Sendai) |
17:20-17:30 | Q&As |
APDW 2018 Plenary Oral 2 | ||
Nov. 16 (Fri) 16:00-17:30 |
Plenary Oral 2 | 205A (2F) |
Chairperson(s) | Kent-Man Chu (Hong Kong), Ming-Shiang Wu (Taipei) | |
16:00-16:10 | The relationship between enterobacterial flora and prognosis in patient with ulcerative colitis | Tomoya Sugiyama (Nagakute) |
16:10-16:20 | Analysis of key genes and signaling pathways involved in helicobacter pylori-associated gastric cancer based on the cancer genome atlas database and RNA-sequencing | Yi Hu (Nanchang) |
16:20-16:30 | Features of post-colonoscopy colorectal cancer and survival times of patients in Korea | Jae Myung Cha (Seoul) |
16:30-16:40 | An open-label, multicenter, randomized controlled trial of vonoprazan versus esomeprazole as part of first-line triple therapy for helicobacter pylori infection | Hiroyuki Tamaki (Takamatsu) |
16:40-16:50 | Evolving the novel per oral endoscopic myotomy and fundoplication (POEM+F) procedure: Application of endoscopic hand-suturing technique | Akiko Ueno (Tokyo) |
16:50-17:00 | POEM is more effective than balloon dilation in all achalasia subtypes: based on data from a single tertiary referral center | Ga Hee Kim (Seoul) |
17:00-17:10 | Simple liquid arrays of three aptamers are valuable for the diagnosis of gastric cancer | Yuting He (Nanchang) |
17:10-17:20 | Deep learning versus simple clinical scores for prediction of advanced neoplasia in colorectal cancer screening | Hyo-Joon Yang (Seoul) |
17:20-17:30 | gut microbiota from patients with colorectal cancer promotes the progression of intestinal adenoma in apcmin/+ mice | Hai-Long Cao (Tianjin) |
E-poster Presentations-09 (UG, Motility) | ||
Nov. 16 (Fri) 16:00-17:30 |
H. pylori, other upper GI disorders | R1A (3F) |
Chairperson(s) | Jae Myung Park (Seoul), Amit Kumar Dutta (Vellore) | |
16:00-16:06 | The study of motor and evacuation functions of the stomach and rectum in patients with functional dyspepsia and irritable bowel syndrome | Oybek Otabekovich Usmonov (Tashkent) |
16:06-16:12 | Objective and subjective approaches in the treatment of patients with GERD with a syndrome of vegetative dystonia | Oybek Otabek O'g'li Usmonov (Tashkent) |
16:12-16:18 | Duodenal eosinophil and mast cell count and its relation with functional dyspepsia; A case control study | Madhusudan Saha (Sylhet) |
16:18-16:24 | Efficacy of endoscopic therapeutic procedures in non variceal upper gastrointestinal bleeding in hanoi medical university hospital from 2013 to 2017 | Hang Dao (Hanoi) |
16:24-16:30 | The association between electronic cigarette smoking and dyspepsia in adult urban population | Ahmad Fariz Malvi Zamzam Zein (Cirebon) |
16:30-15:36 | Current risk factors for peptic ulcer disease in the background of declining frequency of helicobacter pylori infection in patients with dyspepsia | Amit Kumar Dutta (Vellore) |
16:36-16:42 | Impact of upper gastrointestinal symptoms on quality of life in type 2 diabetes patients: preliminary study in Banten province hospital, Indonesia | Laras Budiyani (Serang) |
16:42-16:48 | Systematic review and meta-analysis: prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome | Ayesha Shah (Brisbane) |
16:48-16:54 | The association between peptic ulcer disease and osteoporosis: A 12-year follow up of the Korean genome and epidemiology study | Kanglok Lee (Incheon) |
16:54-17:00 | H. pylori genotyping and genomic diversity assessment ingastric biopsies from residents of high altitude ( ladakh ) and lower plains of north India | Nisha Sharma (Delhi) |
17:00-17:06 | Cost-effectiveness of a tailored helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutation that causes clarithromycin resistance in Korean patients | Seri Ryu (Seoul) |
E-poster Presentations-10 (LG) | ||
Nov. 16 (Fri) 16:00-17:30 |
Inflammatory bowel disease (3) | R1C (3F) |
Chairperson(s) | Jae Hee Cheon (Seoul), Vineet Ahuja (New Delhi) | |
16:00-16:06 | The COX-2/PGE2 pathway is central for efficacy of TNF inhibitors and intestinal epithelial regeneration in ulcerative colitis | Ole Haagen Nielsen (Herlev) |
16:06-16:12 | Using anaemia as an isolated marker to predict the extent of inflammatory bowel disease at diagnosis | Hang Hoi Michael Wong (Hong Kong) |
16:12-16:18 | Predictors of using traditional medicine, complementary and alternative medicine in inflammatory bowel disease in Hong Kong: the first patients self report in ethnic Chinese | Jessica Y L Ching (Hong Kong) |
16:18-16:24 | Age at onset, maintenance therapy and erythrocyte sedimentation rate are independent risk factors for anal fistula in Crohns disease | Guanghui Lian (Changsha) |
16:24-16:30 | Disease activity and severity of ulcerative colitis are associated with increased mucosal candida colonization and Beta-D-Glucan levels | Jimil Hiteshbhai Shah (Chandigarh) |
16:30-15:36 | Incidence and outcomes of acute severe ulcerative colitis (ASUC) - A retrospective cohort study in a Singapore tertiary institution | Kaina Chen (Singapore) |
16:36-16:42 | Molecular detection of pathogenic gut bacteria in inflammatory bowel disease (IBD) patients is not influenced by disease activity | Deborah Chia Hsin Chew (Malaysia) |
16:42-16:48 | Trends in inflammatory bowel disease incidence in Korea: A nationwide population-based study 2004-2015 | Jae Jun Park (Seoul) |
16:48-16:54 | Study of predictive factors and clinical implication of deep mucosal healing in ulcerative colitis | Deepak Gupta (Mumbai) |
16:54-17:00 | Natural history of inflammatory bowel disease from 1970 to 2017 - Results from a large single center in Singapore | Miao Shan Lim (Singapore) |
E-poster Presentations-11 (LV) | ||
Nov. 16 (Fri) 16:00-17:30 |
Autoimmune liver disease, cirrhosis | R2A (3F) |
Chairperson(s) | Il Han Song (Cheonan), Kang Mo Kim (Seoul) | |
16:00-16:06 | Fluorofenidone reveals a novel function for glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and hepatic fibrosis | Yu Peng (Changsha) |
16:06-16:12 | Rapid endoscopic ultrasound screening of hepatopulmonary syndrome (RUSH): a safe, simple and quick procedure for gastroenterologist | Rahul Pundlik Talele (Meerut) |
16:12-16:18 | Outcomes of large volume paracentesis in cirrhotic patients with spontaneous bacterial peritonitis. | Rabeea Azmat (Karachi) |
16:18-16:24 | PXR activation by ginkgolide a restores inflammation and tight junction integrity in cirrhosis | Balasubramaniyan Vairappan (Pondicherry) |
16:24-16:30 | Tofacitinib ameliorates inflammation effectively in immune-mediated hepatic injury | Han Wang (Wuhan) |
16:30-15:36 | The demographic, clinical features, response to treatment and outcome of autoimmune hepatitis (AIH) patients in multi-ethnic Malaysia since 2002 | Yun Chien Chung (Batu Caves) |
16:36-16:42 | The distribution of non-tumoral portal vein thrombosis in liver cirrhosis and its relationship with wall shear stress | Zongfang Li (Xi'an) |
16:42-16:48 | A gravity-assisted liver stiffness measurement | Itsuo Nagayama (Minami Uonuma) |
16:48-16:54 | Repeated versus single treatment of esophageal variceal ligation after esophageal variceal bleeding: Multicenter retrospective study | Young Hwan Choi (Seoul) |
16:54-17:00 | Gastric vascular ectasia (GAVE) not rare cause of GI bleed in liver cirrhosis ; cross sectional study on factors associated with GAVE with or with out portal hypertensive gastropathy (PHG) in liver cirrhosis in tertiary care hospital Karachi Paksitan | Om Parkash (Karachi) |
E-poster Presentations-12 (PB) | ||
Nov. 16 (Fri) 16:00-17:30 |
Endoscopic retrograde cholangiopancreatography (ERCP) | R2C (3F) |
Chairperson(s) | Sang-Woo Cha (Seoul), Ari Fahrial Syam (Depok) | |
16:00-16:06 | Demonstrating competence in endoscopic retrograde cholangiopancreaticography (ERCP): recently credentialed operators performance for deep biliary cannulation over 1 year period from tertiary care hospital in Pakistan. | Om Parkash (Karachi) |
16:06-16:12 | A retrospective comparison of transpancreatic septotomy and needle knife sphincterotomy in difficult biliary cannulation | Cherng Harng Lim (Chanhua) |
16:12-16:18 | The usefulness of newly modified non-flared fully covered metal stent of 12 mm-diameter comparing with conventional stent for periampullary malignant biliary strictures | Jin Yong Lee (Bucheon) |
16:18-16:24 | Bile duct injury after laparoscopic cholecystectomy: new classification and novel approach for the management in emergency situations. | Chintan Patel (Surat) |
16:24-16:30 | Patterns of bile duct injuries observed during endoscopic retrograde cholangiogram: 13 years of experience in a tertiary care referral centre in south Asia | Chamila Lakmal (Colombo) |
16:30-15:36 | Endoscopic management of difficult biliary stones; utility of ERCP using short type double balloon endoscope in patients with surgically altered anatomy | Masaaki Shimatani (Osaka) |
16:36-16:42 | The sphincter-preserving effect of duodenal papilla occlusion by SureClip from MicroTech | Yonghui Huang (Beijing) |
16:42-16:48 | Clinical utility of endoscopic therapy for bile leak associated with posthepatobiliary surgery | Hideyuki Shiomi (Kobe) |
16:48-16:54 | A novel technique using loop-device for the repositioning of ENBD catheter in ERCP | Jae Min Lee (Seoul) |
16:54-17:00 | Efficacy of endoscopic plastic stents for anastomotic biliary strictures after right lobe adult living donor liver transplantation | Min Su You (Seoul) |
17:00-17:06 | Proper initial stent type for palliative bilateral biliary drainage for unresectable advanced malignant hilar obstruction | Young Hoon Choi (Seoul) |
17:06-17:12 | Risk of failure and complications of endoscopic retrograde cholangiopancreatography; comparison of elderly and young pakistani patients | Talal Khurshid (Islamabad) |
AGA-APAGE | ||
Nov. 16 (Fri) 16:00-18:00 |
From bench to clinic in gastric cancer: Where are we headed? | 101 (1F) |
Chairperson(s) | Emad Munir El-Omar (Sydney), Sang Woo Lee (Ansan) | |
16:00-16:25 | The molecular pathogenesis of gastric cancer ? state of the art | Timothy Cragin Wang (New York) |
16:25-16:50 | The role of the gastric microbiome in H. pylori-induced gastric cancer | Richard Peek (Nashville) |
16:50-17:15 | Prevention of gastric cancer ? opportunities and potential problems | Kentaro Sugano (Shimotsuke) |
17:15-17:40 | National gastric cancer screening- outcomes and future challenges | Il Ju Choi (Goyang) |
17:40-18:00 | Q&As |